BioSpace News Archive

23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company, today announced the Company has received a U.S. Food and Drug Administration (FDA) 510(k) clearance to expand its existing BRCA1/BRCA2 (Selected Variants) Genetic Health Risk Report*.

Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its first quarter ended July 31, 2023.

Danaher Corporation will host a live video webcast of Veralto’s Investor and Analyst Meeting on September 6, 2023 beginning at approximately 12:00 p.m. CT.

Sarepta Therapeutics, Inc., the leader in precision genetic medicine for rare diseases, granted equity awards on August 31, 2023 that were previously approved by the Compensation Committee of its Board of Directors under Sarepta’s 2014 Employment Commencement Incentive Plan, as a material inducement to employment to 12 individuals hired by Sarepta in August 2023.

Aditxt, Inc. announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 1,000,000 shares of common stock at a purchase price of $10.00 per share and accompanying warrant, in a private placement priced at-the-market under Nasdaq rules.

Amgen (NASDAQ:AMGN) will present at the 2023 Wells Fargo Healthcare Conference at 9:30 a.m. ET on Wednesday, Sept. 6, 2023. Amgen will also present at the Citi Global Healthcare Conference at 1:00 p.m. ET on Thursday, Sept. 7, 2023.